Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection
Molecular Pharmaceutics · 07.08.2023 · 20 (8) · 3876-3885
DOI: 10.1021/acs.molpharmaceut.2c01024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.07.2023. Verfasst von Asuka Takanashi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics (D4), Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, VIC 3052,…. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Monash University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Delivery, Disposition and Dynamics (D4), Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, VIC 3052, Australia.
ORCID-Profile: Colin W Pouton, Hareth Al-Wassiti
Förderung
- Monash University
Zitieren
APA
Takanashi, A., Pouton, C. W., & Al-Wassiti, H. (2023). Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection. Molecular Pharmaceutics, 20(8), 3876-3885. https://doi.org/10.1021/acs.molpharmaceut.2c01024
Vancouver
Takanashi A, Pouton CW, Al-Wassiti H. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection. Molecular Pharmaceutics. 2023;20(8):3876-3885. doi:10.1021/acs.molpharmaceut.2c01024
BibTeX
@article{Takanashi2023,
author = {Takanashi, Asuka and Pouton, Colin W and Al-Wassiti, Hareth},
title = {Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {8},
pages = {3876--3885},
doi = {10.1021/acs.molpharmaceut.2c01024}
}
EUVIMED